Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 103

Sort by

Sort Order Select

Journal Articles

Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigens

Kyra J. Fuchs, Marian van de Meent, M. Willy Honders, Indu Khatri, Michel G. D. Kester, Eva A. S. Koster, Georgia Koutsoumpli, Arnoud H. de Ru, Cornelis A. M. van Bergen, Peter A. van Veelen, Peter A. C. ’t Hoen, Peter van Balen, Erik B. van den Akker, J. Hendrik Veelken, Constantijn J. M. Halkes, J. H. Frederik Falkenburg, Marieke Griffioen

Blood (2024) 143 (18): 1856–1872.

https://doi.org/10.1182/blood.2023022343

Published: 2024

Includes: Supplemental data

Journal Articles

Energy overpowers sweet tooth in FL

Hendrik Veelken

Blood (2023) 142 (26): 2226–2229.

https://doi.org/10.1182/blood.2023022268

Published: 2023

Journal Articles

Artificial Intelligence Approach for the Discovery of Autoantigen Recognition By B-Cell Lymphomas

David Medina, Julieta Sepulveda-Yanez, Diego Alvarez-Saravia, Roberto Uribe-Paredes, Hendrik Veelken, Marcelo Navarrete

Blood (2023) 142 (Supplement 1): 125.

https://doi.org/10.1182/blood-2023-187238

Published: 2023

Journal Articles

Detection of Occurrent Somatic Hypermutation and Associated Gene Expression Profile in Single B Cells

Julieta Sepulveda-Yanez, Diego Alvarez-Saravia, David Medina, Edwin Quinten, Szymon M. Kiełbasa, Marcelo Navarrete, Cornelis A.M. van Bergen, Hendrik Veelken

Blood (2023) 142 (Supplement 1): 4139.

https://doi.org/10.1182/blood-2023-190074

Published: 2023

Journal Articles

Randomized Trial of Prophylactic Donor Lymphocyte Infusion with Positively Selected CD4+ T Cells after HLA-Identical Allogeneic Stem Cell Transplantation

Joost Van Der Hem, Peter Van Balen, Sabrina Veld, Peter A. Von Dem Borne, Danielle Van Lammeren, Tjeerd Snijders, Jaap Jan Zwaginga, Hendrik Veelken, Rosa De Groot, Inge Jedema, Liesbeth C. de Wreede, Constantijn Halkes, J.H. Frederik Falkenburg

Blood (2023) 142 (Supplement 1): 6887.

https://doi.org/10.1182/blood-2023-188843

Published: 2023

Journal Articles

B-Cell Receptor Function and Gene Expression Profiling at Single-Cell Level across the Spectrum from Normal to Neoplastic CD5-Positive B-Cell Compartments in Humans

Edwin Quinten, Julieta Sepulveda-Yanez, Ramin Monajemi, Roberta Menafra, Susan L. Kloet, Szymon M. Kiełbasa, Cornelis A.M. van Bergen, Hendrik Veelken

Blood (2023) 142 (Supplement 1): 1885.

https://doi.org/10.1182/blood-2023-189097

Published: 2023

Journal Articles

Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL

Blood (2023) 142 (13): 1131–1142.

https://doi.org/10.1182/blood.2023020195

Published: 2023

Includes: Supplemental data

Journal Articles

Antigen-Independent, Autonomous B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma

Janneke A. Eken, Marvyn T. Koning, Julieta H. Sepulveda Yanez, Cornelis A.M. van Bergen, Edwin Quinten, Kristyna Kupcova, Ondrej Havranek, Ruben A.L. De Groen, Joost S.P. Vermaat, Daphne de Jong, Philip Kluin, Arjen Cleven, Hassan Jumaa, Hendrik Veelken

Blood (2022) 140 (Supplement 1): 6444–6445.

https://doi.org/10.1182/blood-2022-159420

Published: 2022

Journal Articles

Immunotherapy Targeting Mutant Nucleophosmin-1 on Acute Myeloid Leukemia

Georgia Koutsoumpli, Dyantha I. van der Lee, Nina C. Groenland, M. Willy Honders, Rob C.M. de Jong, Renate S. Hagedoorn, Hendrik Veelken, Peter A. van Veelen, Dominik Lock, Mirjam H.M. Heemskerk, J.H.Frederik Falkenburg, Ian Johnston, Marieke Griffioen

Blood (2022) 140 (Supplement 1): 10243–10244.

https://doi.org/10.1182/blood-2022-158195

Published: 2022

Journal Articles

Effects of HLA Mismatches on Cytokine Release Syndrome and Associated Non-Relapse Mortality in Allogeneic Stem Cell Transplantation with Post-Transplant Cyclophosphamide

Peter A. Von Dem Borne, Berit M. Kemps-Mols, Liesbeth C. de Wreede, Adriaan A. van Beek, Tjeerd J.F. Snijders, Danielle van Lammeren, Janneke Tijmensen, Aniko Sijs-Szabo, Theo L. Nering Bögel, Mirjam A. Oudshoorn, Constantijn J.M. Halkes, Peter van Balen, Erik W.A.F. Marijt, Jennifer M.L. Tjon, Joost S.P. Vermaat, Hendrik Veelken

Blood (2022) 140 (Supplement 1): 4735–4736.

https://doi.org/10.1182/blood-2022-157012

Published: 2022

Journal Articles

Prophylactic Donor Lymphocyte Infusion in Patients after Allogeneic Stem Cell Transplantation with Post-Transplant Cyclophosphamide Is Associated with Low Relapse Risk and Excellent Survival in Patients below 65 Years with Acute Myeloid Leukemia and High-Risk Myelodysplasia

Peter A. Von Dem Borne, Tjeerd J.F. Snijders, Danielle van Lammeren, Janneke Tijmensen, Erwin V. Planken, Henriette Levenga, Yascha van den Berg, Erik WAF Marijt, Peter van Balen, Jennifer M. Tjon, Joost S.P. Vermaat, Theo L. Nering Bögel, Mirjam A. Oudshoorn, Constantijn J.M. Halkes, Hendrik Veelken

Blood (2022) 140 (Supplement 1): 7742–7743.

https://doi.org/10.1182/blood-2022-157894

Published: 2022

Journal Articles

Polyostotic DLBCL Is Characterized By a NF-Κb Pathway Affecting Molecular Profile and Superior Survival

Blood (2022) 140 (Supplement 1): 3534–3536.

https://doi.org/10.1182/blood-2022-159036

Published: 2022

Journal Articles

Autonomous BCR Signaling and Genetic Aberrations in CLL-Phenotype Monoclonal B Lymphocytosis in Siblings of CLL Patients

Julieta H. Sepulveda Yanez, Edwin Quinten, Marvyn T. Koning, Janneke A. Eken, Dietmar Pfeifer, Ruben A.L. De Groen, Diego Alvarez Saravia, Andreas Agathangelidis, Cornelis A.M. van Bergen, Kostas Stamatopoulos, Joost S.P. Vermaat, Katja Zirlik, Marcelo Navarrete, Hassan Jumaa, Hendrik Veelken

Blood (2022) 140 (Supplement 1): 1526–1527.

https://doi.org/10.1182/blood-2022-169429

Published: 2022

Journal Articles

Consolidation Improves Survival in Primary Central Nervous System Lymphoma without Preference for Type of High-Dose Methotrexate-Based Induction Treatment Regimen

Blood (2022) 140 (Supplement 1): 369–371.

https://doi.org/10.1182/blood-2022-163244

Published: 2022

Journal Articles

Molecular Diagnostics for TP53 Is Recommended in B-Cell Lymphomas

Lorraine M. De Haan, Ruben A.L. De Groen, Fleur de Groot, Troy Noordenbos, Tom van Wezel, Ronald van Eijk, Dina Ruano, Arjan Diepstra, Lianne Koens, Aniko Sijs-Szabo, Hendrik Veelken, Arjen Cleven, Patty M. Jansen, Joost S.P. Vermaat

Blood (2022) 140 (Supplement 1): 11916–11918.

https://doi.org/10.1182/blood-2022-163197

Published: 2022

Journal Articles

Impact of Specific Adverse Cytogenetic Features on Outcomes after Allogeneic Hematopoietic Cell Transplantation in Myelodysplastic Syndrome with Very Poor Risk Cytogenetics: A Study from the Chronic Malignancies Working Party of EBMT

Blood (2021) 138 (Supplement 1): 3953.

https://doi.org/10.1182/blood-2021-150892

Published: 2021

Journal Articles

Tandem Substitutions in Somatic Hypermutation

Marvyn T. Koning, Julieta Haydee Sepulveda Yanez, Diego Alvarez-Saravia, Bas Pilzecker, Pauline Van Schouwenburg, Mirjam van den Burg, Marcelo A. Navarrete, Heinz Jacobs, Hendrik Veelken

Blood (2021) 138 (Supplement 1): 996.

https://doi.org/10.1182/blood-2021-153604

Published: 2021

Journal Articles

"Snapshotting" Somatic Hypermutation in Single Follicular Lymphoma Cells

Juleta H. Sepulveda-Yanez, Diego Alvarez-Saravia, Edwin Quinten, Roberta Menafra, Susan L. Kloet, Ramin Monajemi, Szymon M. Kielbasa, Marcelo Navarrete Signorile, Cornelis A.M. van Bergen, Hendrik Veelken

Blood (2021) 138 (Supplement 1): 1151.

https://doi.org/10.1182/blood-2021-150475

Published: 2021

Journal Articles

Transplantation for Congenital Sideroblastic Anaemia Is Feasible and Offers Outcomes Comparable to Other Transfusion Dependent Anaemias. a Joint Retrospective Study of the Paediatric Diseases and Severe Aplastic Anaemia Working Parties (PDWP/SAAWP) of EBMT

Blood (2020) 136 (Supplement 1): 45–47.

https://doi.org/10.1182/blood-2020-142397

Published: 2020

Journal Articles

Allogeneic Hematopoietic Cell Transplantation in Patients with Therapy-Related Myeloid Neoplasm after Breast Cancer: A Study of the Chronic Malignancies Working Party of the EBMT

Blood (2020) 136 (Supplement 1): 3–4.

https://doi.org/10.1182/blood-2020-137773

Published: 2020

NARROW

Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigens

Energy overpowers sweet tooth in FL

Artificial Intelligence Approach for the Discovery of Autoantigen Recognition By B-Cell Lymphomas

Detection of Occurrent Somatic Hypermutation and Associated Gene Expression Profile in Single B Cells

Randomized Trial of Prophylactic Donor Lymphocyte Infusion with Positively Selected CD4+ T Cells after HLA-Identical Allogeneic Stem Cell Transplantation

B-Cell Receptor Function and Gene Expression Profiling at Single-Cell Level across the Spectrum from Normal to Neoplastic CD5-Positive B-Cell Compartments in Humans

Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL

Antigen-Independent, Autonomous B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma

Immunotherapy Targeting Mutant Nucleophosmin-1 on Acute Myeloid Leukemia

Effects of HLA Mismatches on Cytokine Release Syndrome and Associated Non-Relapse Mortality in Allogeneic Stem Cell Transplantation with Post-Transplant Cyclophosphamide

Prophylactic Donor Lymphocyte Infusion in Patients after Allogeneic Stem Cell Transplantation with Post-Transplant Cyclophosphamide Is Associated with Low Relapse Risk and Excellent Survival in Patients below 65 Years with Acute Myeloid Leukemia and High-Risk Myelodysplasia

Polyostotic DLBCL Is Characterized By a NF-Κb Pathway Affecting Molecular Profile and Superior Survival

Autonomous BCR Signaling and Genetic Aberrations in CLL-Phenotype Monoclonal B Lymphocytosis in Siblings of CLL Patients

Consolidation Improves Survival in Primary Central Nervous System Lymphoma without Preference for Type of High-Dose Methotrexate-Based Induction Treatment Regimen

Molecular Diagnostics for TP53 Is Recommended in B-Cell Lymphomas

Impact of Specific Adverse Cytogenetic Features on Outcomes after Allogeneic Hematopoietic Cell Transplantation in Myelodysplastic Syndrome with Very Poor Risk Cytogenetics: A Study from the Chronic Malignancies Working Party of EBMT

Tandem Substitutions in Somatic Hypermutation

"Snapshotting" Somatic Hypermutation in Single Follicular Lymphoma Cells

Transplantation for Congenital Sideroblastic Anaemia Is Feasible and Offers Outcomes Comparable to Other Transfusion Dependent Anaemias. a Joint Retrospective Study of the Paediatric Diseases and Severe Aplastic Anaemia Working Parties (PDWP/SAAWP) of EBMT

Allogeneic Hematopoietic Cell Transplantation in Patients with Therapy-Related Myeloid Neoplasm after Breast Cancer: A Study of the Chronic Malignancies Working Party of the EBMT

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only